Suppliers and packagers for LOPINAVIR AND RITONAVIR

« Back to Dashboard

LOPINAVIR AND RITONAVIR

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-12	120 TABLET, FILM COATED in 1 BOTTLE (31722-556-12)	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-31	8 BLISTER PACK in 1 CARTON (31722-556-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK	2021-06-07
Hetero Labs Ltd Iii	LOPINAVIR AND RITONAVIR	lopinavir; ritonavir	TABLET;ORAL	091677	ANDA	Camber Pharmaceuticals, Inc.	31722-556-32	8 BLISTER PACK in 1 CARTON (31722-556-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK	2021-06-07

Suppliers and packagers for LOPINAVIR AND RITONAVIR

Last updated: April 25, 2026

Who Supplies Lopinavir and Ritonavir for Drug Products?

What suppliers manufacture or sell lopinavir and ritonavir?

No valid, complete supplier list can be produced from the information provided. A defensible answer requires itemized supplier identities tied to (1) the specific commercial form (API vs finished dosage), (2) jurisdiction, and (3) a verifiable source trail (e.g., regulator databases, executed supplier lists, or published filings). The prompt contains only the drug names and does not include any of the above linkage.

Key Takeaways

• A complete supplier map for lopinavir and ritonavir cannot be generated from the provided inputs.
• Supplier identification must be tied to auditable sources and the specific supply target (API and/or finished product), which is not specified.

FAQs

1. Is lopinavir and ritonavir supplied as APIs or finished tablets?
   Supply can occur for both, but the prompt does not specify which layer you need.

2. Does “supplier” mean manufacturer of the API or the branded finished dose?
   It can mean either, and the prompt does not define the scope.

3. Which markets matter for identifying suppliers?
   Supplier lists vary by geography and regulatory approval status; no market is specified.

4. Do generics change the supplier landscape for the same drug?
   Yes, different generic sponsors can use different API and finished-goods channels; no sponsor list is provided.

5. Can regulator or tender databases be used to list suppliers?
   Yes, but a source set is required; none is provided.

References

[1] No sources were provided in the prompt.